Finance

Lists
Q3 2026 earnings • 3:00 PM tomorrow
See details
FME:ETR
Fresenius Medical Care AG
€40.45
+0.12%
(+0.050) 1D
ኖቬም 2, 4:29:54 ከሰዓት ጂ ኤም ቲ+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FME...
Open
€40.14
High
€40.85
Low
€40.05
Mkt. cap
10.88 ቢ
Avg. vol.
835.74 ሺ
Volume
298.95 ሺ
Dividend
3.68%
Quarterly dividend
€0.37
Ex-dividend date
22 ሜይ 2026
P/E ratio
12.16
52-wk high
€46.66
52-wk low
€34.57
EPS
€3.33
Shares outstanding
268.56 ሚ
No. of employees
107 ሺ
Open
€40.14
High
€40.85
Low
€40.05
Mkt. cap
10.88 ቢ
Avg. vol.
835.74 ሺ
Volume
298.95 ሺ
Dividend
3.68%
Quarterly dividend
€0.37
Ex-dividend date
22 ሜይ 2026
P/E ratio
12.16
52-wk high
€46.66
52-wk low
€34.57
EPS
€3.33
Shares outstanding
268.56 ሚ
No. of employees
107 ሺ
News stories
From web sources and news partners
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives. With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan. The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue. As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOHelen Giza
Employees107 ሺ
Founded1996
Headquarters-
SectorHealth care provider
Next call in 21:14:54
Tomorrow, 3:00 ከሰዓት
Fiscal period
Q3 2026
- / €1.20
Revenue / Est. (EUR)
- / 4.91 ቢ
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
4.88 ቢ
5.07 ቢ
4.61 ቢ
4.86 ቢ
Cost of goods sold
3.64 ቢ
3.68 ቢ
3.43 ቢ
3.55 ቢ
Cost of revenue
3.64 ቢ
3.68 ቢ
3.43 ቢ
3.55 ቢ
Research and development expenses
37.75 ሚ
38.63 ሚ
38.31 ሚ
39.63 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
705.44 ሚ
784.62 ሚ
748.94 ሚ
736.01 ሚ
Operating expense
740.50 ሚ
796.34 ሚ
803.94 ሚ
786.35 ሚ
Total operating expenses
4.38 ቢ
4.48 ቢ
4.24 ቢ
4.34 ቢ
Operating income
501.72 ሚ
592.03 ሚ
375.56 ሚ
523.63 ሚ
Other non operating income
-
-
-
-
EBT including unusual items
402.57 ሚ
508.46 ሚ
207.52 ሚ
383.00 ሚ
EBT excluding unusual items
462.70 ሚ
541.79 ሚ
334.44 ሚ
399.22 ሚ
Income tax expense
75.22 ሚ
106.44 ሚ
42.75 ሚ
89.83 ሚ
Effective tax rate
18.69%
20.93%
20.60%
23.45%
Other operating expenses
-2.69 ሚ
-26.91 ሚ
16.69 ሚ
10.71 ሚ
Net income
274.80 ሚ
327.08 ሚ
117.53 ሚ
218.38 ሚ
Net profit margin
5.63%
6.45%
2.55%
4.49%
Earnings per share
1.10
1.44
0.91
0.56
Interest and investment income
19.16 ሚ
13.62 ሚ
14.62 ሚ
14.70 ሚ
Interest expense
-93.10 ሚ
-99.02 ሚ
-93.30 ሚ
-97.55 ሚ
Net interest expenses
-73.94 ሚ
-85.40 ሚ
-78.68 ሚ
-82.86 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
853.56 ሚ
780.17 ሚ
727.79 ሚ
879.38 ሚ
Gain or loss from assets sale
50.35 ሚ
17.92 ሚ
8.77 ሚ
-4.09 ሚ
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች